Present role and future prospects of positron emission tomography in clinical oncology

被引：66

作者：

Oriuchi, Noboru

Higuchi, Tetsuya

Ishikita, Tomohiro

Miyakubo, Mitsuyuki

Hanaoka, Hirofumi

Iida, Yasuhiko

Endo, Keigo

机构：

[1] Gunma Univ, Grad Sch Med, Dept Diagnost Radiol & Nucl Med, Maebashi, Gumma 3718511, Japan

[2] Gunma Univ, Grad Sch Med, Dept Stomatol & Maxillofacial Surg, Maebashi, Gumma 3718511, Japan

[3] Gunma Univ, Grad Sch Med, Dept Bioimaging Informat Anal, Maebashi, Gumma 3718511, Japan

来源：

CANCER SCIENCE | 2006年 / 97卷 / 12期

关键词：

D O I：

10.1111/j.1349-7006.2006.00341.x

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Positron emission tomography (PET) has emerged as a significant molecular imaging technique in clinical oncology and cancer research. PET with F-18-fluorodeoxyglucose (F-18-FDG) demonstrates elevated glucose consumption by tumor cells, and is used clinically for the accurate staging and restaging of cancer, planning of radiotherapy, and predicting response or lack of response in the early stages of treatment. Combined PET and computed tomography (PET-CT) provides both functional and morphological information of the disease to allow accurate diagnosis of cancer. PET with new radiotracers such as protein synthesis markers and proliferation markers, as well as hypoxia and receptor-binding agents, will offer patient-specific images in order to yield tailored diagnostic and prognostic information.

引用

页码：1291 / 1297

页数：7

共 55 条

[1]

Amano S, 1998, J NUCL MED, V39, P1424

[2] Pharmacokinetics of the thymidine analog 2′-fluoro-5-methyl-1-β-D-arabinofuranosyluracil (FMAU) in tumor-bearing rats [J].

Bading, JR ;

Shahinian, AH ;

Vail, A ;

Bathija, P ;

Koszalka, GW ;

Koda, RT ;

Alauddin, MM ;

Fissekis, JD ;

Conti, PS .

NUCLEAR MEDICINE AND BIOLOGY, 2004, 31 (04) :407-418

[3] Biologic correlates of 18fluorodeoxyglucose uptake in human breast cancer measured by positron emission tomography [J].

Bos, R ;

van der Hoeven, JJM ;

van der Wall, E ;

van der Groep, P ;

van Diest, PJ ;

Comans, EFI ;

Joshi, U ;

Semenza, GL ;

Hoekstra, OS ;

Lammertsma, AA ;

Molthoff, CFM .

JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (02) :379-387

[4] FDG pet studies during treatment:: Prediction of therapy outcome in head and neck squamous cell carcinoma [J].

Brun, E ;

Kjellén, E ;

Tennvall, J ;

Ohlsson, T ;

Sandell, A ;

Perfekt, R ;

Wennerberg, J ;

Strand, SE .

HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2002, 24 (02) :127-135

[5]

Buck AK, 2002, CANCER RES, V62, P3331

[6] The accuracy of endoscopic ultrasonography with fine-needle aspiration, integrated positron emission tomography with computed tomography, and computed tomography in restaging patients with esophageal cancer after neoadjuvant chemoradiotherapy [J].

Cerfolio, RJ ;

Bryant, AS ;

Ohja, B ;

Bartolucci, AA ;

Eloubeidi, MA .

JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2005, 129 (06) :1232-1241

[7] POSITRON EMISSION TOMOGRAPHY WITH FLUORODEOXYGLUCOSE TO EVALUATE TUMOR RESPONSE AND CONTROL AFTER RADIATION-THERAPY [J].

CHAIKEN, L ;

REGE, S ;

HOH, C ;

CHOI, Y ;

JABOUR, B ;

JUILLARD, G ;

HAWKINS, R ;

PARKER, R .

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1993, 27 (02) :455-464

[8] Positron emission tomographic assessment of "metabolic flare" to predict response of metastatic breast cancer to antiestrogen therapy [J].

Dehdashti, F ;

Flanagan, FL ;

Mortimer, JE ;

Katzenellenbogen, JA ;

Welch, MJ ;

Siegel, BA .

EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1999, 26 (01) :51-56

[9] Assessing tumor hypoxia in cervical cancer by positron emission tomography with 60Cu-ATSM:: Relationship to therapeutic response -: A preliminary report [J].

Dehdashti, F ;

Grigsby, PW ;

Mintun, MA ;

Lewis, JS ;

Siegel, BA ;

Welch, MJ .

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2003, 55 (05) :1233-1238

[10]

Dimitrakopoulou-Strauss A, 1998, J NUCL MED, V39, P1197

← 1 2 3 4 5 6 →